Manipulations of the immune checkpoints PD-1 and CTLA-4 are among the immune escape mechanisms of cancer cells and the PD-1/PD-L1 pathway seems to play a pivotal role in the development of a tumor-tolerant TME in BTC [137,138]. The gene discussed is CD274; the disease is neoplasm.